In-House Preparation and Quality Control of Ac-225 Prostate-Specific Membrane Antigen-617 for the Targeted Alpha Therapy of Castration-Resistant Prostate Carcinoma

PURPOSE: Ac-225 labeled with prostate-specific membrane antigen (PSMA-617), a transmembrane glycoprotein which is highly expressed in prostate carcinoma cells, is presently being considered a promising agent of targeted alpha therapy for the treatment of patients suffering from metastatic castration...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakral, Parul, Simecek, Jakub, Marx, Sebastian, Kumari, Jyotsna, Pant, Vineet, Sen, Ishita Barat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320836/
https://www.ncbi.nlm.nih.gov/pubmed/34385780
http://dx.doi.org/10.4103/ijnm.ijnm_200_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320836/
https://www.ncbi.nlm.nih.gov/pubmed/34385780
http://dx.doi.org/10.4103/ijnm.ijnm_200_20

Ejemplares similares